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Although our understanding of the pathophysiology of birth asphyxia has increased
considerably over the last twenty-five years, the effects of asphyxia on brain development
remain controversial. In this paper I will deal with the definition and incidence of birth
asphyxia, the etiology of intrapartum asphyxia and the outcome measures which have been
used in randomized controlled trials of fetal intensive care. In addition, I will discuss the
relationship of birth asphyxia to the subsequent development of hypoxic-ischaemic
encephalopathy and cerebral palsy.
1. The Definition and Incidence of Birth Asphyxia
The definition of asphyxia as given in Webster's New World Dictionary is "loss of
consciousness as a result of too little oxygen and too much carbon dioxide in the blood."
Thus, the dictionary gives both a biochemical and a biophysical definition. The biochemical
definition can be precisely determined in terms of pH, PCO2 and PO2 and usually takes the
form of a combined respiratory and metabolic acidosis. However, a biophysical definition, i.e.,
the Apgar scoring system, has been widely used for many years exclusive of any biochemical
definition.
The true incidence of birth asphyxia is difficult to determine from the literature. Only those
papers in which consecutive deliveries were reported are considered here so that bias from
inclusion or exclusion of specific data is avoided. Table 1 shows the results of studies which
satisfy these criteria and in which a biochemical definition for birth asphyxia was used, based
on the pH of umbilical cord blood at birth.
It can be seen from Table 1 that the incidence of birth asphyxia depends on the precise pH
chosen to define acidosis. If the definition used is that of pH < 7.1, the incidence varies
from 2.3% to 8.6%, whereas, if the definition is widened to pH < 7.2, the incidence varies from
4.8% to 21.6%. There seems to have been consistent improvement in the incidence of low pH
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at birth over the years between 1972 and 1987. This is particularly evident in the figures
obtained from Dr. Saling's unit (2,5). Indeed, the recent figures emerging from their unit show
that less than 5% of babies are now born with a UA pH of less than 7.2.
Table I Incidence of Birth Asphyxia in Consecutive Deliveries
Based on Umbilical Cord Blood pH
Source UA/UV Mean ± SD Low pH
Kubli 1972(1)
Boenisch & Saling
1974(2)
Sykes et al 1982(3)
MacDonald et al
1985(4)
van den Berg et al
1987(5)
3317
5724
899
1075
2669
UA
UA
UA
UV
UA
7.26(median)
-
7.20 ± .08
7.30 ± .07
7.30 ± .07
<7.2 -21.1%
<7.1 - 4.4%
<7.2 -10.6%
<7.1 - 2.3%
<7.1 - 8.6%
<7.1 - 1.5%
<7.2 - 4.8%
UA=umbilical artery UV=umbilical vein
An exception is the data of Sykes et al (3) which shows the highest incidence of acidosis (pH
< 7.1) of all the studies. However, it is possible that methodological errors may account for
their low pH values since pH was not always measured immediately after collection of blood
samples.
It is difficult to compare the data from MacDonald et al (4) with the remainder of the data in
Table 1 since the vessel chosen for blood sampling was the umbilical vein. Umbilical venous
blood will not provide a satisfactory measure of acidosis in the fetus particularly under
conditions of umbilical cord compression (see later) and the low incidence of acidosis reported
by this group in over 1000 consecutive deliveries may reflect this problem.
It can be concluded that there are a number of problems in the biochemical definition of birth
asphyxia. Firstly, if pH is to be used as the criteria, there is no agreement on the absolute
value of pH which should be considered as abnormal. Should we use a pH value of 7.2 or 7.1
and should we use other parameters in addition such as PO2, O2 saturation, PCO2 or lactate
values? Secondly, if umbilical cord blood is used in the biochemical determination, the
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duration of asphyxia is not known and there is no clear indication of whether the acidosis is
chronic and long-standing or has developed acutely over the last few minutes of labour and
delivery. The long-term prognosis of these two situations may be entirely different, and
continuous biochemical monitoring may be the only way to monitor the duration of an
asphyxial episode.
In many centres a biophysical score, usually the Apgar score or a modification of Apgar score,
is the only criterion used for a diagnosis of birth asphyxia. The data which has been
obtained from consecutive deliveries has been examined (Table 2), and there are wide
variations in the definition and incidence using a low Apgar score, similar to those found
using pH to define asphyxia.
Table 2 Incidence of Birth Asphyxia Defined by Apgar Score
Source n Apgar %
Drage et al 1964(6) 10,020 <7 at 5 min 4.0%
Boenisch & Saling 1974(1) 5,724 <7 at 1.5 min 6.7%
Sykes et al 1982(2) 895 <4 at l min 3.8%
Macdonald et al 1985(4) 13,084 <4 at 1 or 5 min 1.0%
van den Berg et al 1987(5) 2,669 <7 at 1.5 min 1.05%
The definition of birth asphyxia by Apgar score is complicated by the presence of both false
positives and false negatives (7,8). False positives (low Apgar and normal pH) can be seen
with prematurity, analgesia, anaesthesia, trauma at delivery and congenital malformations.
False negatives (normal Apgar and low pH) can be seen with short term asphyxia, chronic
asphyxia in which fetal adaptation has occurred, and maternal metabolic acidosis.
A combined scoring system using both low Apgar score and low pH has been advocated by
some authors (2, 5) and the results of three studies in which this combined approach to
scoring at birth has been used is shown in Table 3; again, only those papers in which
consecutive deliveries were studied are presented here. This type of approach in which not
only the biochemical definition of asphyxia is used but also the effect on the fetus and
newborn is taken into consideration, seems to be the most logical one in that it considers the
functional effects of the biochemical abnormality.
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Table 3 Incidence of Birth Asphyxia Defined as Low pH
and Low Apgar in Consecutive Deliveries
Low UA pH Low Apgar Low pH + Low Apgar
Boenisch & Saling <7.2 10.6% <7 at 1.5 min 6.7% 3.2%
1974(2)
Sykes et al 1982(3) <7.1 8.5% <7 at l min 10.8% 2.2%
van den Berg <7.2 4.8% <7 at 1.5 min 1.5% 0.7%
1987(5)
2. Etiology of Intraoartum Birth Asphyxia
The underlying cause of birth asphyxia is impaired placental gas exchange and the common
pathological events leading to this situation during the intrapartum course are listed in Table
4.
Not included in this list are problems which precede the intrapartum course such as acute or
chronic maternal hypertension, maternal or fetal cardiac failure, intrauterine growth failure
and placental insufficiency. However, impairment of placental exchange before the onset of
labour will considerably increase the intrapartum risk of asphyxia.
Table 4 Intrapartum Causes of Birth Asphyxia
1. Reduction of Uterine Blood Flow
e.g. increased uterine activity
maternal hypotension
2. Reduction of Umbilical Blood Flow
e.g. umbilical cord compression
3. Combined Reduction of Maternal-Fetal Blood Flow
e.g. abruptio placenta
second stage (increased uterine activity
+ cord compression)
There is usually a decline in pH during the course of labour and particularly during the
second stage. Kubli (1) showed that there was a shift in median pH from 7.31 in early first
stage to slightly lower values in late first stage. Median values for the second stage were
7.25 with a wide scattering of values below 7.1. Our own data, obtained from a small group
of healthy women (n=28) in normal labour who were followed throughout first and second
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stages with multiple fetal blood samples, showed a similar decline in pH in the second stage of
labour (Figure 1).
Fetal pH fell from a mean of 7.30 in scalp blood samples during labour to 7.24 in umbilical
cord blood at birth. It should be noted that pH was well maintained throughout the first
stage and even early second stage, only falling when the second stage had been in progress
for more than thirty minutes. Note that maternal pH also fell during the second stage due to
the development of a mild metabolic acidosis without any change in PCO2, presumably due to
lactic acidosis from the physical activity involved in bearing down efforts. In contrast, the
acidosis which developed in the fetus was due to a combination of respiratory and metabolic
acidosis (Figure 1).
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Figure 1 Mean values for pH, PCO2 and base excess in maternal venous and fetal capillary(scalp) blood during normal labour and delivery in a group of healthy women
(n=28). UA = umbilical artery; UV = umbilical vein.
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Umbilical cord entanglement which was present in about 34% of 749 patients monitored in
labour in our own data, is probably the commonest cause of fetal acidosis. pH values in
umbilical arterial blood were significantly lower when cord entanglement was present (Table 5),
although there was no difference in umbilical venous blood pH.
The explanation for maintenance of umbilical venous blood pH in the presence of umbilical
cord compression is that maternal blood flow through the placenta remains uninterrupted while
reduced blood flow through the umbilical circulation can satisfactorily maintain exchange with
the mother at least in the early phases of cord compression. As a consequence of this, there
is a significantly wider difference in pH between umbilical arterial and venous blood when
cord complications are present (Table 5).
Table 5 Umbilical Arterial (UA) and Umbilical Venous (UV) Blood pH (mean ± SD)
at Birth in the Presence or Absence of Cord Entanglement
Cord Entanglement
Absent Present
n=473 n=246
UApH
UVpH
UV-UA pH
7.29 ± .074
735 ± .068
0.06 ± .034
7.26 ± 0.098
7.35 ± 0.077
0.08 ± .054
p<0.005
n.s.
p<0.001
Cord compression has also been studied in fetal lambs (9). Figure 2 shows results from
experiments in fetal lambs at 127 to 142 days gestation in which the umbilical cord was mildly
compressed for a period of thirty minutes. The anticipated changes in pH, PO2, PCO2 and
lactate can be seen from Figure 2 although the degree of compression was such that pH only
fell from 7.36 to 7.26 during the thirty minute period. Changes in fetal brain electrocortical
(ECoG) activity, although not significantly different, showed a trend towards increased high
voltage activity during cord compression which promptly reverted to a normal percentage of
time spent in high voltage and low voltage activity in the post-compression period. This
suggests that even mild degrees of asphyxia may be accompanied by changes in functional
activity of brain cells.
In one experiment in a fetal lamb, the umbilical cord was severely compressed for a period of
twelve minutes. Figure 3 shows portions of the electrocortical (ECoG) activity from the fetal
brain before, during and after compression. It can be seen that ECoG activity disappeared
completely at 2-3 minutes after the start of cord compression i.e., at a time when pH had
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only fallen from 7.39 to 7.30. The most significant change during this period was a dramatic
fall in PO2 from 25.6 to 5.5 mm Hg within two minutes of compression.
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Figure 2 Effects of mild umbilical cord compression on fetal acid-base state and
electrocortical (ECoG) activity in three fetal lambs at 127-142 days gestation.
All experiments performed at >7 days after surgical preparation.
There was also a very large increase in lactate which only slowly resolved following
compression. Lactate values remained elevated for at least three hours after the cord was
released, presumably due to the slow washout of lactate from tissues once peripheral
circulation was re-established during recovery from asphyxia. Similarly ECoG activity showed
a slow return to its normal cyclical pattern of high voltage and low voltage activity. It is
anticipated that experiments of this type will help to show how the biochemical defect in
asphyxia impinges on tissue function and could provide valuable insight into the normal
recovery patterns of cellular function.
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3. Outcome Measures in Birth Asohvxia
The effects of birth asphyxia are listed in Table 6 as modified from Fomufod et al (10) and
deSa (11). Although the effects of asphyxia on the metabolism and the central nervous system
are the most obvious at birth, there may be multi-organ dysfunction with widespread effects
on bone marrow, kidneys, lungs, gastrointestinal tract and cardiovascular system in as many as
76% of infants affected (10). Widespread ischaemic damage may culminate in neonatal death or
death in early infancy.
Table 6 Effects of Intrapartum Asphyxia on
the Fetus and the Newborn Infant
Metabolic
- metabolic acidosis, hypoglycemia,
hypocalcemia, hyponatremia
CNS
- hypoxic-ischaemic encephalopathy
- neonatal seizures
- brain swelling
- long term neurological handicaps
Haematologic
- thrombocytopenia, DIG
Renal Damage
Pulmonary
- hyaline membrane disease
- persistent fetal circulation
Gastrointestinal
- necrotizing enterocolitis
- liver dysfunction
Cardiovascular
- bradycardia, hyper/hypotension
- myocardial necrosis
Perinatal Death
Modified from Fomufod et al (10); deSa (11)
Much of the effort in obstetrical perinatal care over the past two decades has been directed
towards development of sophisticated monitoring technics for fetal intensive care during
labour. To date, the results of most randomized controlled trials using continuous fetal heart
rate monitoring as a method of preventing perinatal asphyxia have been disappointing. Table
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7 lists those studies which conform to the stringent criteria of truly randomized controlled
trials. As can be seen, there have been no significant differences in any of the trials to date
in either perinatal mortality or Apgar score.
Table 7 Randomized Controlled Trials of Continuous
Fetal Heart Rate Monitoring
Source
Haverkamp et al(12)
Haverkamp et al(13)
Renou et al(14)
Kelso et al(15)
MacDonald et al(4)
Year
1976
1978
1976
1978
1985
n
483
695
344
504
12,964
Perinatal
Mortality
n.s
n.s
n.s
n.s
n.s
Apgar
Score
n.s
n.s
n.s
n.s
n.s
Umbilical
Arterial
Blood pH
n.s
n.s
p<0.05J
"no diff ."
n.s2
Neurol-
ogical
Outcome
n.s
n.s
p<0.001
n.s
p=0.025
n.s = not significant l η = 86 2 η = 1000; umbilical venous blood
pH has only been shown to be significantly different in one study in which pH was lower in
unmonitored patients; however, the number of patients involved was small. It is unfortunate
that in the Dublin randomized controlled trial (4) involving the largest number of patients,
only 1000 of their patients were evaluated with umbilical cord blood pH and the vessel chosen
was the umbilical vein and not the umbilical artery. Thus, no conclusions can be drawn from
their data regarding the effect of monitoring on the biochemical outcome for the fetus.
In contrast, neurologic outcome has been shown to be significantly different in at least two
trials (4, 14) with a higher incidence of jitteriness and early neonatal seizures in unmonitored
patients. It should be noted that, in the Dublin randomized controlled trial (4), biochemical
assessment of the fetus was permitted in both arms of the study. Thus, the difference in
neurologic outcome was attributed to the application of continuous fetal heart rate monitoring
and not to the use of fetal blood sampling.
The data from randomized controlled trials suggests that perinatal mortality and Apgar score
will not be useful measures of outcome in any future trial of fetal intensive care. The
current low level of perinatal mortality and its multiple etiology make it a poor choice as an
outcome measure for birth asphyxia. Similarly, Apgar score alone, because of high false
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negative and false positive rates in relation to fetal acidosis, is not a good measure for the
presence or absence of birth asphyxia. The presence of fetal acidosis unrelated to maternal
acidosis is diagnostic of impaired placental exchange and should be included in a definition of
birth asphyxia. However, the absence of fetal acidosis does not exclude the possibility that
episodes of asphyxia, from which the fetus has since recovered, may have preceded labour and
delivery. Finally, neurologic outcome can be regarded as an important outcome measure to
which we should pay close attention in the future.
Although Apgar score may not be a good measure of birth asphyxia, it is the only one that
has been used for many years and a large volume of data available from the National
Collaborative Perinatal Project (1955-1966) has been based on this outcome measure. Apgar
scores were recorded in approximately 49,000 infants at 1 and 5 minutes and the presence or
absence of cerebral palsy was known in 37,000 children who were available for follow up at 7
years of age. This data was subsequently analyzed by Nelson and Ellenberg (16) and the
development of cerebral palsy compared with Apgar score at birth. The mortality rate was
very high for infants <2500 gm at the time this data was collected. Furthermore, the
etiology of cerebral palsy in low birth weight infants is known to be correlated with postnatal
as well as prenatal factors. For these reasons, I have only considered their data from term
infants of >2500 gm. Infants with very low Apgar scores of 0-3 showed an increasing
mortality during the first year of life and an increasing morbidity (cerebral palsy) related to
the latest time interval after birth at which an Apgar score of 0-3 was recorded (Table 8). It
should be noted, however, that of the 120 children known to have cerebral palsy at 7 years of
age which was not acquired postnatally, 55% had Apgar scores of 7-10 at 1 minute and 73%
had scores of 7-10 at 5 minutes. Since the majority of infants will have normal Apgar scores
at birth, the largest single group of children with cerebral palsy can be expected to come
from this group, while a minority will come from groups with low Apgar scores.
It is clear from this data that a severely depressed infant at birth, particularly one that
remains depressed and does not respond to resuscitation, has an increased risk of cerebral
palsy related to the time interval over which it remains depressed after birth. However, many
infants show no signs of birth asphyxia as judged by the Apgar score and it is therefore
unlikely that their subsequent developmental problems can be attributed to intrapartum
asphyxia. Indeed, it is more likely that, in this group, the cause of cerebral palsy antedates
the intrapartum period and may or may not be related to asphyxia. The probability that
factors preceding labour and delivery are very important in subsequent development of cerebral
palsy has been pointed out by a multivariate analysis of the data from the National
Collaborative Perinatal Project (17). This analysis showed that maternal mental retardation,
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birth weight below 2001 grams and fetal malformation were among the leading predictors of
cerebral palsy.
Table 8 Apgar Scores and Outcome by Latest Very Low Apgar Score (0-3)
(> 2500 gm)
Apgar 0-3
(time-mins)
1
5
10
15
20
Liveborn
1729
286
66
23
39
Death in
First Yr (%)
3.1
7.7
18.2
47.8
59.0
Known
to 7 Yrs.
1330
217
43
11
14
With Cerebral
Palsy (%)
0.7
0.9
4.7
9.1
57.1
From Nelson & Ellenberg, 1981 (16)
Breech presentation was also a predictor although breech delivery was not. Forty of the 189
survivors with cerebral palsy had evidence of birth asphyxia as judged by low Apgar score at
birth. However, 23/40 or 57.5% had other factors present which were predetermined before
the onset of labour such as birth weight below 2001 grams, congenital malformation etc. This
data supports the idea that many fetuses are already predestined to develop cerebral palsy
even before the onset of labour and that intrapartum asphyxia is responsible for a relatively
small percentage of infants who eventually show neurologic developmental problems.
In 1982, Dennis and Chalmers (18) proposed that very early neonatal seizure rate could be
used as a strong indicator of the quality of care based on their analysis of babies who
developed seizures in the first forty-eight hours of life. They suggested that morbidity
indices should be based on neonatal clinical signs which were unambiguous and strongly
predictive of later morbidity such as cerebral palsy. Thus they proposed that the frequency of
neonatal seizures in the first forty-eight hours of life should be considered as an index which
met these criteria with respect to full term babies. The analysis of data from randomized
controlled trials also suggested that, although the seizure rate did not achieve statistical
significance in most of the studies, there was a trend towards a higher seizure rate in the
unmonitored group. Thus, the Dublin randomized controlled trial was designed to use neonatal
seizures as an outcome measure. Table 9 reproduced from that study (4) shows that there
were twice as many infants with early neonatal seizures in the control (auscultated) group as
in the electronic fetal monitoring group (p < 0.025) and the neonatal death rate following
development of seizures was also twice as high (p < 0.05).
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Table 9 Dublin RCT of Intrapartum Electronic Fetal Monitoring (EFM)
Sequelae of
Neonatal Seizures
Neonatal death
Survival
Total no. of seizures
Relative Risk
(95% confid.)
EFM
3
2
12
.45
Auscultation
6
21
27
1.0
Significance
p < 0.05
p < 0.025
From MacDonald et al. (4)
Hypoxic-ischaemic encephalopathy (HIE) is the term used to identify the cerebral problems in
the full term infant following intrapartum or neonatal asphyxia. The pathological lesions are
located in the peripheral and dorsal areas of the cerebral cortex and involve necrosis of the
gyri at the depths of the sulci and neuronal nuclei of the basal ganglia and brain stem (19).
The clinical features of HIE have been classified by Sarnat and Sarnat (20) into three stages:
stage I - hyperalert stage II - lethargic and hypotonic; stage III - stuporous and flaccid. In
a careful follow up of survivors to 3.5 years of age, Robertson and Finer (21) used a similar
classification into mild, moderate and severe HIE. They showed that none of the mild HIE
cases died and none were handicapped at follow up (Table 10). However, with moderate and
severe HIE, mortality and morbidity rates progressively increased with severity of the disorder
and all survivors in the severe HIE group were handicapped.
Table 10 Outcome to 3.5 Yrs after Hypoxic-ischaemic Encephalopathy
in 226 Term Infants
HIE n (Lost to Deaths
Follow-up) In Hosp. Later
Follow-up at 3.5 Yrs
Not Hand. Handicapped
Mild 79
Moderate 119
Severe 28
(10)
(16)
(0)
-
3
14
-
3*
7
69
75
-
-
22
7
* 1 death from MVA From Robertson & Finer (21)
The type of handicap described by Robertson and Finer (21) ranged from cognitive delay
(58%), to cerebral palsy (53%), convulsive disorders (34%), visual loss ( 29%) and deafness
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(11%). Thus the development of moderate or severe HIE within the first few days of life is a
strong indicator of perinatal asphyxia and of subsequent morbidity.
Finally, the follow up study by Low et al (22) is the only one to date which relates careful
intrapartum monitoring including acid base measurements with subsequent follow 'up of the
child and neurologic assessment. They determined the development of intrapartum asphyxia by
a measure of umbilical arterial blood buffer base and they classified their deficits at one year
follow up as major or minor, motor and/or cognitive problems and showed an increasing
incidence of deficits as buffer base values declined from 34 mmol/1 to <22 mmol/1 (Figure 4).
100%
CO
50% ·
34 30 26 22 <20
METABOLIC AC I DOS l S U.A.BB mEq/L
IBS Major Deficits M Minor Deficits
Figure 4 The incidence of major or minor, motor and/or cognitive deficits increased from
20% to 80% as the umbilical artery buffer base decreased from 30-34 to <22 mEq/1.
(Reproduced with permission granted by C.V. Mosby Co. From Low, J.A. et al 1984
Am. J. Obstet. Gynecol. 148. 533-539.)
Summary
1. Rates for perinatal mortality and low Apgar scores have not been affected by fetal
intensive care (electronic monitoring + fetal blood sampling) in any randomized controlled trial
to date.
2. Acidosis at birth may be susceptible to improvement by fetal intensive care but has not
been tested adequately in more than a few women.
3. Birth asphyxia which is followed by evidence of cerebral dysfunction within the first 48
hours of life can be significantly altered by current technics of fetal intensive care.
4. The evidence suggests that cognitive disorders and cerebral palsy occur as long term
sequelae of hypoxic-ischaemic encephalopathy in a small percentage of survivors. However,
factors which predate the onset of labour are more likely to be responsible for cerebral palsy
than factors associated with labour.
5. Future developments might include the following:
(i) To establish that umbilical arterial pH and/or lactate and/or Apgar score is predictive for
neonatal outcome such as hypoxic-ischaemic encephalopathy or other markers of asphyxia.
(ii) To determine whether umbilical arterial pH and/or lactate is significantly different when
continuous biochemical monitoring is used versus traditional intermittent fetal blood sampling,
i.e. does continuous monitoring prevent acidosis?
In the present state of development of continuous biochemical monitoring technics in labour it
seems unlikely that, at the present time, we could answer the larger question of whether such
monitoring can prevent the neurological complications of hypoxic-ischaemic encephalopathy and
the subsequent developmental problems including cerebral palsy.
Finally, we must not forget that labour and delivery represents a relatively small time period
in relation to the total duration of pregnancy with a ratio of approximately 1:355. Thus, it is
not surprising that many of the problems of neurologic development are difficult to trace back
to a particular stage in pregnancy. Careful monitoring of labour and delivery may help to
counteract the tendency to blame this period of pregnancy for all subsequent developmental
problems of the child.
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